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Abstract
Gene expression is controlled by the concerted interactions between transcription factors and chromatin regulators. While
recent studies have identified global chromatin state changes across cell-types, it remains unclear to what extent these
changes are co-regulated during cell-differentiation. Here we present a comprehensive computational analysis by
assembling a large dataset containing genome-wide occupancy information of 5 histone modifications in 27 human cell
lines (including 24 normal and 3 cancer cell lines) obtained from the public domain, followed by independent analysis at
three different representations. We classified the differentiation stage of a cell-type based on its genome-wide pattern of
chromatin states, and found that our method was able to identify normal cell lines with nearly 100% accuracy. We then
applied our model to classify the cancer cell lines and found that each can be unequivocally classified as differentiated cells.
The differences can be in part explained by the differential activities of three regulatory modules associated with embryonic
stem cells. We also found that the ‘‘hotspot’’ genes, whose chromatin states change dynamically in accordance to the
differentiation stage, are not randomly distributed across the genome but tend to be embedded in multi-gene chromatin
domains, and that specialized gene clusters tend to be embedded in stably occupied domains.
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Introduction
Multi-cellular organisms are composed of diverse cell types that,
despite sharing the same genome, are programmed with distinct
gene expression patterns. How such diversity is regulated
mechanistically is a fundamental biological question. Eukaryotic
DNA is packaged in chromatin. The fundamental unit of
chromatin is nucleosome, a histone octamer, which wraps around
147 bp DNA. The N-terminal tails of histone proteins are
decorated by different marks resulting from covalent modifica-
tions. The combinatorial patterns of these marks, which we refer
to as the chromatin states, may recruit specific regulatory proteins,
which in turn control transcription [1,2].
Recent genome-wide location studies have identified distinct
chromatin states that demarcate regulatory elements [3,4,5,6,7].
Furthermore, the chromatin states changes significantly between
different cell types, in accordance with gene expression level
changes [3,8,9,10,11,12,13,14,15], providing strong evidence that
the chromatin states play an important role in development. On
the other hand, these studies have been limited to comparing a
small number of cell types. As a result, it is difficult to evaluate to
what extent cell lineages are associated with chromatin states.
Characterization of the molecular signatures associated with cell
lineages will not only provide insights into the transcription control
but help identifying the cell-of-origin, which is an important task
for many diseases. For example, an intensively investigated area of
cancer research is whether a tumor is originated from cancer stem
cells or normal differentiated cells. Understanding the origin of
cancer cells has important implications in developing therapeutic
methods.
The idea of using genomic data to classify cell lineages is not
new. There have been extensive studies based on gene expression
data (reviewed by [16]). However, one major limitation is that
gene expression levels do not inform us the underlying controlling
mechanism, which is fundamental for understanding developmen-
tal processes and diseases. For example, gene expression analyses
have discovered the intriguing phenomenon that tumors with poor
clinical outcome often display a signature that is similar to stem
cells [17]. However, the underlying mechanism remains incom-
pletely understood. Recently, it has been shown that the similarity
is mainly due to the activity of the MYC regulatory module rather
than the core module targeted by pluripotent factors [18].
Recently, a large amount of genome-wide histone modification
data have been generated and made publicly available, in part due
to the effort of ENCODE and Roadmap Epigenomics consortia
[15,19]. These data have provided a great opportunity to identify
general principles of chromatin regulation. In this paper, we will
focus on evaluating the association between chromatin states and
cell differentiation stages. To this end, we assembled a large
dataset from the public domain of genome-wide locations of 5
histone modifications in 27 human cell lines and analyzed the data
independently using four different spatial representations (see
Figure 1 for a schematic overview). We found that cell
differentiation status can be classified with nearly 100% accuracy
from chromatin states alone, that chromatin state switches are
frequently associated with multi-gene domains, and that the
PLoS ONE | www.plosone.org 1 February 2012 | Volume 7 | Issue 2 | e31414cancer cell lines have similar chromatin states as differentiated
cells.
Results
An assembly of genome-wide data for 5 histone
modifications in 27 human cell lines
We collected genome-wide histone modification data from NIH
Epigenome Roadmap [20] and other public domains [4,11,13,21].
We focused on five histone modifications that have been profiled
extensively, including four associated with active genes
(H3K4me1, H3K4me3, H3K36me3, H3K9ac) and one associated
with gene silencing (H3K27me3). We focused on 27 human cell
lines for which data for all five modifications are available,
including 24 normal and 3 cancer cell lines (Table S1). Of the 24
normal cell lines, five are pluripotent cells (P), four are multipotent
(M), which may further differentiate into multiple cell-types; and
the others are either unipotent progenitors or terminally
differentiated cells, which were grouped together (U/D). The
three cancer cell lines are: K562 (chronic myelogenous leukemia),
HeLa (cervical cancer), and VCaP (prostate cancer).
To systematically compare different length scales, we analyzed
the data independently based on three different representations,
corresponding to increasing complex signatures: (1) the bin level
sequence reads; (2) the gene-level summary scores associated with
each histone mark; and (3) the combinatorial patterns of multiple
histone marks referred to as the chromatin states (see Materials
and Methods for more details).
In previous work [22], we developed a hidden Markov model
(HMM) to identify chromatin states, treating each gene as a unit.
Here we applied this approach to analyze the ChIP-seq dataset for
the 27 human cell lines. As before, we determined the number of
chromatin states based on the gap statistic [23] (see Materials and
Methods for details), and found that the optimal number of
clusters is 3 (Figure S1). This is the same number of chromatin
states we identified previously for mouse data [22]. We found the
genome-wide pattern is described by three HMM states: active
(associated with active marks), non-active (associated with
H3K27me3), and null (lack of both active and repressive marks)
(Table S2). We applied a common model to infer genome-wide
chromatin states in all cell lines (Table S3). As the non-active state
is associated with relative high density of both H3K27me3 and
H3K4me3, we were also interested to test if there was a significant
overlap with the bivalent domains. Indeed, we found that 25.8%
of genes containing bivalent domains correspond to the nonactive
state (Figure S2). On the other hand, we also found that 67.0% of
bivalent domains correspond to the active state. These genes are
typically associated with higher density of additional active marks
such as H3K4me1 and H3K36me3. This observation is consistent
with a recent study showing that a subset of genes marked by
bivalent domains are actively transcribed [24], but it also suggests
that the chromatin states may be further refined.
Histone modification patterns accurately classify cell
differentiation status
We wanted to compare our three methods of analyzing ChIPseq
data (i.e., the bin, gene, and chromatin state levels) to determine
which one is the ‘best’ at classification of cell lineages, which were
grouped by the differentiation status: P, M, or U/D. For each
representation, we built a support vector machine (SVM) model to
classify the membership of a cell line based on the histone
modification data (see Materials and Methods). In order to avoid
overfitting, we evaluated the classification accuracy using leave-
one-out cross-validation. The classification accuracy was quanti-
fied by the percentage of agreement between the model predicted
and true differentiation status. Surprisingly, we found that all
representations led to 100% accuracy (compared to 62% obtained
by using the null model, which classifies every cell line as the
Figure 1. Overview of the data analysis strategy. ChIPseq data of 5 histone modifications in 27 human cell lines were obtained from the public
domains and analyzed independently using four different representations (bin, gene score, and chromatin state level). For each representation, a
support vector machine (SVM) model was used to classify cell differentiation status from histone modification data. ‘‘Hotspot’’ genes or bins were
detected by ANOVA and further investigated by functional genomic tools. The SVM model obtained from normal cell lines was used to classify the
differentiation status of cancer cell lines.
doi:10.1371/journal.pone.0031414.g001
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on a particular approach, we repeated the analysis by using the
radial kernel function instead and again achieved 100%
classification accuracy. These results strongly suggest that distinct
chromatin states are associated with different differentiation
statuses. This striking difference prompted us to further dissect
biological features of these distinctive chromatin states and to
pursue the utility of chromatin states for the classification of poorly
characterized cell-types.
Numerous locations of epigenetic difference found
between cell lines
To gain functional insights, we searched for regions that are
most discriminative across different cell lineages: P, M, or U/D.
To this end, we applied a permutation ANOVA F- test and
selected those regions (bins or genes) that are differentially
modified (FDR,0.05) (See Materials and Methods for detail).
Indeed we found extensive differences at each level.
Bin level: Our ANOVA analysis identified 249,705 differential
bins for the H3K4me1 analysis, 21,224 bins for H3K4me3, 5,354
bins for H3K9ac, 25,385 bins for H3K27me3, and 69,373 bins for
H3K36me3 (Table S4). On the other hand, only 7 differential bins
were common to all five modifications (Figure S3a), consistent with
the previous results that they each demarcate different regions
[4,9]. While the H3K27me3 and H3K4me1 bins are distributed
quite uniformly across the genome, the other three modifications
showed a strong bias toward coding regions, promoters, CpG
islands and shores (Figure S3b). Interestingly, while the mean
occupancy levels of H3K4me3 and H3K9ac are highest in
promoter regions, the variance can be high in coding regions as
well. Conversely, while H3K36me3 is known to be mainly
targeted toward coding regions, the variance can also be high in
promoter regions.
Gene level: We found 2,501 genes that are differential based
on their H3K4me1 gene-level score, 2,119 genes for H3K4me3,
368 genes for H3K9ac, 569 genes for H3K27me3, and 4,731
genes for H3K36me3 (Table S5). For most of these genes, the
gene-level scores are higher in pluripotent cells than multipotent
and differentiated cells (Figure 2a, and Figures S4b–e). Again, the
overlap between different modifications is low: only 4 genes were
common to all modifications (Figure S4a).
Chromatin state level: By applying our ANOVA analysis to
the chromatin state information obtained by our hidden Markov
model, we found 722 differential genes, which were analyzed
further. We call these genes the ‘‘hotspot’’ genes to highlight their
role in chromatin state remodeling (Table S6). We observed two
main patterns of chromatin state switch during cell differentiation
(Figure 2b): 1) most ‘‘hotspot’’ genes are in the nonactive state in
pluripotent cells and switch to the null state in differentiated cells;
2) a smaller subset of genes are in the active state in pluripotent
cells and switch to another state during differentiation. Interest-
ingly, most ‘‘hotspot’’ genes are in the null state in U/D cells. A
closer examination suggested that a number of additional genes
were also marked by H3K4me3 and H3K9ac, although the gene-
level scores tended to be lower compared to the active state. 244 of
these hotspot genes display distinct chromatin state pattern in ES
cells compared with the other cell lines (Table S7). Among these
244 genes, 209 are in the non-active state in ES cells.
To gain functional insights, we applied the Database for
Annotation, Visualization and Integrated Discovery (DAVID) [25]
to identify enriched functional categories that are associated with
the ‘‘hotspot’’ genes. We found significant enrichment of genes
associated with the Homeobox, cell-cell signaling, or neuron
development (Figure 3a), consistent with an important role of
chromatin state remodeling during development.
In addition, those ‘‘hotspot’’ genes that undergo different
remodeling paths during cell differentiation tend to be associated
with different biological functions. Specifically, the genes that are
active in pluripotent cells (such as HIST1H4F) tend to be
associated with chromatin organization and methylation, the
Figure 2. Differentiation related variation of histone modification patterns. (a) Heatmap showing the gene-level H3K4me1 scores for the
100 most significantly different genes. (b) Heatmap of the chromatin states for the 722 ‘‘hotspot’’ genes, whose chromatin states are significantly
different across differentiation statuses. Red – active state; yellow – null state; blue – nonactive state. The cell line information is shown at both sides
of the heatmap and color-coded by the differentiation status (black – pluripotent cells (P); red – multipotent (M); green – unipotent/differentiated (U/
D)).
doi:10.1371/journal.pone.0031414.g002
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genes) are usually involved in organism development, while the
genes that are in the null state in pluripotent cells (such as APOL6)
seem to participate in diverse biological processes (Figure S5).
Our functional analysis also identified four signaling pathways
enriched in the ‘‘hotspot’’ genes: neuroactive ligand-receptor
interaction (p-value=0.0017), calcium-signaling (p-value=0.006),
hedgehog-signaling (p-value=0.008), and TGF-Beta signaling
pathway (p-value=0.013). The hedgehog-signaling pathway is
particularly interesting since it plays an essential role in embryo
segmentation and is conserved from flies to humans [26]. There
are four ‘‘hotspot’’ genes (adjusted p-value,0.05) in this pathway,
including SHH, SMO, WNT, and ZIC2 (Figure 3b), suggesting
that chromatin state remodeling may play an important role in
regulating the cell-type specific activity of this important pathway.
Likewise the TGF-Beta signaling pathway is involved in embryo
differentiation, left-right axis determination, apoptosis and meso-
derm/endoderm development [27].
Coordinated switches in chromatin domains
We were interested in finding the extent to which developmen-
tally related chromatin state remodeling was spatially coordinated.
As before [22], we merged neighboring genes of the same state
into blocks, and identified chromatin domains as those blocks that
were significantly larger than expected by chance (see Materials
and Methods for detail). We found that 1,874 genes were
contained in a significant domain in at least two cell lines. In the
following we refer to these as the domain-associated genes.
1,874 genes are found in the domain-associated group.
Interestingly, we found there is a significant overlap between this
group and the ‘‘hotspot’’ genes identified by our ANOVA analysis.
11.2% of the ‘‘hotspot’’ genes fall into this category (p-
value=0.0346). In addition, the genes that are significant only
in one modification are also strongly associated (p-value,0.01).
These results suggest that chromatin state remodeling does not
occur by random but is regulated in a spatially coordinated
manner, perhaps through active maintenance of the domain
boundaries.
One of the classical examples of chromatin domains is the
HOXB gene cluster (Figure 4a). In particular, in the ES cell lines,
the genes found in this domain are in the non-active state, which is
characterized by high H3K27me3 occupancy. In differentiated
cells, the HOXD genes switched to the null state. The histone gene
cluster on chromosome 6 also undergoes a domain-level change
during cellular differentiation (Figure 4b). These genes are mostly
in the active state in ES cells, and then some of them
(HIST1H14D to HIST1H3G) switch to a null state for most of
the multipotent cell lines. There is then a switch back to a mostly
non-active state for the unipotent/differentiated cell lines.
A small subset (containing 171 genes) of the domain-associated
genes are persistent in the sense that they are embedded in a
domain in almost every cell type (n.21). This set of genes consists
of specialized gene clusters, such as the olfactory receptor (OR)
clusters, the keratin-associated protein cluster, and the Leukocyte
Ig-like receptors (LIRs) cluster. These gene clusters tend to be
silenced in almost every cell type except for few highly specialized
cell types such as the olfactory receptors, keratin cells, or
leukocytes. Consistent with gene silencing, these genes are not
associated with active histone modifications.
Histone modification patterns in cancer cells are similar
to differentiated cell types
The high accuracy of our chromatin-based classification models
suggests that it may be useful for classification of poorly
characterized cell-types. Cancer cells do not follow normal cell
differentiation pathway and their lineages are poorly character-
ized. It has been noted that cancer cells often display character-
istics similar to stem cells. Our above results suggested that
chromatin states can be used to provide mechanistic insights into
the relationship between cancer and stem cells. To this end, we
applied our classification models to three cancer lines (K562,
HeLa, VCaP), for which we were able to obtain the histone
Figure 3. Functional enrichment analysis of the ‘‘hotspot’’ genes. A total of 722 ‘‘hotspot’’ genes were identified by applying ANOVA analysis
to the chromatin states. Enriched functions and pathways were identified by using DAVID. (a) Representative enriched functional categories. (b) The
Hedgehog signaling pathway is significantly enriched (p-value=0.008). The genes were color-coded based their corresponding adjusted p-values
obtained from ANOVA analysis.
doi:10.1371/journal.pone.0031414.g003
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classified as U/D (Table 1), suggesting significant and robust
chromatin structural differences between cancer and stem cells
(either pluripotent or multipotent cells).
We further investigated the association between chromatin state
changes and known regulatory modules. In a recent study, Kim et
al. identified three ES regulatory modules based on protein-DNA
interaction data [18]. These modules correspond to target genes of
core ES cell regulators such as OCT4 and NANOG (called the
Core module); of Polycomb group complexes (called the PRC
module); and of the MYC related regulators (called the MYC
module), respectively. These authors found that the gene
expression patterns of cancer and stem cells are similar for the
MYC module but significantly different for the other two modules.
These observations led us to compare the chromatin state
organization at these modules between different cell-types. As a
simple quantitative metric, we evaluated the fraction of genes
within each module falling into the non-active state (Figure 5a).
The difference between different cell-lineage groups is apparent.
Furthermore, the cancer cell lines seem to be distinct from the
stem cells (either pluripotent or multipotent).
To test whether the activity of these modules is sufficient to
explain the differences among differentiation stages, we built a
multinomial logistic regression model to classify differentiation
status solely based on the three module-specific chromatin
signatures (see Materials and Methods). This simple model already
has 88% classification accuracy. We then applied this module-
based model to classify the differentiation status of the three cancer
cell lines. The results are similar to those obtained from the full
SVM models. All three cancer cell lines (HeLa and VCaP) were
classified as U/D. Therefore, the differences between cancer cells
and stem cells can be interpreted simply by the differential activity
of the three ES regulatory modules.
We divided the cell lines into groups of similar chromatin states
by hierarchical clustering (Figure 5b). Both pluripotent cells and
multipotent cells form distinct clusters, providing additional
support to our classification results. Interestingly, two of the three
U/D cell lines that were clustered together with multipotent cells
may also be viewed as somewhat undifferentiated, since they are
both fibroblasts and can undergo further differentiation and
become more specialized. On the other hand, the three cancer cell
lines are not only clustered with U/D cell lines but also positioned
next to the cell lines from the same germ-layer.
In addition, we found that 290 genes have different chromatin
state patterns compared to the normal differentiated cells (Table
S8). 197 of these genes are in the non-active state in cancer cells.
Only 10 genes from this list overlap with the ‘‘hotspot’’ genes that
differentiating normal cell lines across differentiation stages,
suggesting that these cancer cell lines contain additional chromatin
signature that is distinct from normal differentiated cell lines.
Functional analysis suggested that these genes are enriched with
genes associated with nucleosome organization (p-value=0.0002).
Figure 4. Representative chromatin domains identified by the hidden Markov model. Heatmap of the chromatin state distribution at the
local genomic loci. (a) the HOXB gene cluster; (b) The histone gene cluster. Genes are ordered according to their genomic positions. Red – active
state; yellow – null state; blue – nonactive state. The cell line information is shown at both sides of the heatmap and color-coded by the
differentiation status (black – plutipotent (P) cells; red – multipotent (M); green – unipotent/differentiated (U/D)).
doi:10.1371/journal.pone.0031414.g004
Table 1. Outcome of classifying the differentiation status of
three cancer cell lines (K562, HeLa, and VCaP) by applying the
support vector machine to histone modification data at
different levels.
K562 HeLa VCaP
Bin (5 models) 0/0/5 1/0/4 0/0/5
Gene, single mark (5 models) 0/0/5 0/0/5 0/0/5
Chromatin state (1 model) 0/0/1 0/0/1 0/0/1
The results are represented as three numbers, corresponding to the number of
models for which the cell line classified as pluripotent (P), multipotent (M), or
unipotent/differentiated (U/D), respectively.
doi:10.1371/journal.pone.0031414.t001
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multiple human diseases
Aberrant epigenetic regulation has been linked to many
diseases, including cancer, endocrine, and respiratory diseases
[28,29]. We hypothesized that such alteration may be partially
contributed to intrinsic variability that occurs during normal
differentiation and reasoned that, if so, the ‘‘hotspot’’ genes
identified by our study should be significantly associated with
various diseases.
By using the DAVID analysis tool again, we found that the
‘‘hotspot’’ genes are significantly associated with chemical
dependency diseases (adjusted p-value=0.0075; associated genes
include HTR2C, CHRNA4, and APOE), developmental disease
(adjusted p-value=0.0081; associated genes include NLGN3, and
GLO1), and physiological diseases (adjusted p-value=0.0092;
associated genes include APOL2 and OXT). In contrast, we did
not find any cancer type with significant association, with the
lowest adjusted p-value at 0.92 (for prostate carcinoma). This lack
of association further supports our view that chromatin states in
cancer cells are fundamentally different from stem cells.
Discussion
Through a systematic analysis of a large dataset containing 5
histone modifications in 27 human cell lines at three different
representations, we found that the chromatin states can classify cell
differentiation stages with nearly 100% accuracy. To our
knowledge, this is the first study to classify cell differentiation
stages based on chromatin information. Our results strongly
suggest that the chromatin states are co-regulated at each
developmental stage. We identified 722 ‘‘hotspot’’ genes, whose
chromatin states are significantly associated with the differentia-
tion stages. These genes are enriched with functions related to
development, cell-cell signaling, and chromatin structure.
The success of our classification model led us to test if it can be
used to gain insights into the origin of cancer cells. To this end, we
applied our model to classify three cancer cell lines for which we
obtained genome-wide histone modification data from the public
domains, including K562 (chronic myelogenous leukemia), HeLa
(cervical cancer), and VCaP (prostate cancer). We found that these
cancer cells can be unequivocally classified as differentiated cells
based on the chromatin states, and that the differences between
cancer and stem cells can be interpreted simply by using the three
regulatory modules identified in ES cells [18]. Furthermore, all
three cancer cell lines were clustered next to cell lines from the
same germ layer, suggesting they may indeed originate from
normal differentiated cells. Our analysis has provided new insights
into the different regulatory mechanisms between cancer and stem
cells. In future work, it will be very interesting to characterize the
chromatin states in tumor samples and to investigate to what
extent the chromatin states are associated with clinical outcome.
Recent studies have identified large-scale domains formed by
various epigenetic marks [12,13,30]. A major difference between
our and the aforementioned studies is that we treat each gene as a
distinct unit, thereby ignoring the interruption of histone
modification patterns at intergenic regions which may not be
relevant for gene regulation. This allowed us to identify active
domains despite the absence of active histone marks in intergenic
regions. We also found that the ‘‘repressive’’ domains can be
further divided into two types: ‘‘non-active’’ and ‘‘null’’. Their
main difference is that, while the ‘‘non-active’’ domains are
associated with high H3K27me3 activity, the null domains do not
appear to be associated with any histone mark. It will be
interesting to further investigate that the null domains may be
associated with certain repressive histone marks that are not
included here. These two domain types also differ functionally.
The non-active domains are associated with poised gene
activation, and the null domains seem to be able to achieve more
stable gene silencing and therefore are desirable for the regulation
of highly specialized gene clusters such as keratin and olfactory
receptors.
The extensive presence of null domains was first discovered in
mouse ES cells, where we found that many OR genes were
associated with this pattern [22]. The functional relevance has
been supported by a recent experimental study, which showed that
the transition from the null state to a new state marked by
Figure 5. Cancer cells display similar chromatin state patterns as fully differentiated cells. (a) A scatter plot of cell-type specific chromatin
states associated with the three ES regulatory modules. The chromatin state of a module is summarized by the fraction of non-active-state genes.
Each data point corresponds to one cell-type and is color-coded according to the differentiation status. The three cancer cells are labeled. (b)
Hierarchical clustering of the 27 cell lines based on the chromatin states.
doi:10.1371/journal.pone.0031414.g005
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development of olfactory neurons [31]. Our analysis here has
extended these previous studies, suggesting that transition from
null states may be a general mechanism for control of cell-type
specific gene regulation. It will be very interesting to experimen-
tally test this hypothesis in future studies.
Materials and Methods
Raw data processing
Bin level: Raw ChIP-seq data were divided into 100 bp bins
via BEDTools [32] and normalized to reads per million reads
(RPM) to allow comparison across cell lines. Bins that overlapped
50% or more with known repetitive regions [33] were removed
from further analysis. Remaining bins were merged into
1 kilobase (Kb) regions. The bins with no reads in any cell line
were removed. Ultimately, we were left with 2,388,489 bins for
further analysis.
Gene level: Gene annotations were based on Refseq [34].
Promoter regions were defined as the [22 Kb, +2 Kb] region with
respect to transcription start sites (TSS). For H3K4me1,
H3K4me3, H3K27me3 and H3K9ac, the gene-level scores were
defined by averaging normalized sequence reads over each gene
promoter. For H3K36me3, it has been shown that the sequence
reads are highest at 80–95% of the coding region of a gene [4]; the
gene-level scores were defined as by averaging over these regions.
After removing the genes that substantially overlap with repetitive
regions, we were left with 18,385 genes for further investigation.
Chromatin state level: The chromatin states were detected
using a hidden Markov model (HMM) as previously described
[22]. Briefly, the HMM combines gene-level scores for all five
histone modifications (the emission variable) and classifies them as
distinct chromatin states (the hidden variable). For simplicity, the
emission probability is modeled by a multivariate Gaussian
distribution with no covariance structure. To determine the
optimal number of chromatin states, we clustered these five-
dimensional vectors using the k-means average agglomeration
clustering method. The optimal cluster number k was selected
using the gap statistic [23] defined as
Gap k ðÞ ~E log Wk ðÞ ðÞ {log W 
k
  
where W
*
k is the observed within-cluster sum of squares around
the clusters means for one run, and E(?) represents the mean value
for 1000 random bootstrap permutations. The gap statistic is
maximized at k=3 (Figure S1).
We initially fit a three-state model separately for each cell line
on chromosome 22, and used the expectation-maximization (EM)
algorithm to estimate these model parameters. These cell-type
specific models were averaged to obtain a single common model,
which was then applied to determine the genome-wide chromatin
states in the 27 cell lines via the Viterbi algorithm [35].
The bivalent genes were identified similar to the traditional
definition [3], but with the modification necessary to map to the
bin-level data. Specifically, we identified all the bivalent bins, that
is, those 1 Kb bins that overlap with both H3K4me3 and
H3K27me3 peak locations, where the peak locations were
detected by adapting the CisGenome algorithm to bin-level data
[36]. The bivalent genes were identified as those whose promoter
overlaps with at least one bivalent bin.
Domain level: For each cell line, consecutive genes sharing
the same chromatin states were merged as domains. As in previous
work [22], we further used a likelihood-ratio test to identify
significant domains in order to remove those domains that simply
occur by chance. Specifically, for each domain, we calculated the
ratio of the likelihood of observing its corresponding gene-level
scores under the assumption that they were in the common
chromatin state to the likelihood of observing the same data under
the null hypothesis of no domain states. We estimated the null
distribution based on 1,000 random permutations of all genes, and
selected a cutoff domain size corresponding to the false discovery
rate (FDR) at 0.05. Only those domains larger than the cutoff size
were deemed significant and retained for further analysis. This
analysis was repeated separately for each cell line; therefore the
results are independent of the composition of cell lines in our
assembly. A gene that is embedded in a significant domain in at
least two cell lines is called domain-associated.
Cell differentiation stage classification
We classified the differentiation status [pluripotent (P), multip-
otent (M), or unipotent/differentiated (U/D)] from histone
modification data by using support vector machines (SVM) [37]
using either linear
K xi,xj
  
:w xi ðÞ
Tw xj
  
:xT
i xj
or radial
K xi,xj
  
:w xi ðÞ
Tw xj
  
:exp {c xi{xj
       2   
(where c.0, and is estimated by cross-validation) kernel functions
[38]. To determine which of the three ChIP-seq data represen-
tations (i.e., the bin, gene, and chromatin state levels) is most
informative, we analyzed each representation independently. For
the gene level analyses, all genes were used. For fair comparison,
an equal number (i.e. equal to the number of genes) of most
variable bins were used to construct the model. Calculations were
done with the R package e1071 [39].
A simple classification model based on three regulatory
modules
Using the three ES regulatory modules (described in the main
text), we fit the following multinomial logistic regression model on
the 24 normal cell lines:
log
pij
p 
ij
 !
~azxT
i bj, j=j 
where pij is the probability that the i
th cell line (i=1, 2, …, 24) is a
member of differentiation class j (j=1, 2, 3)and xi is the percentage
of genes in one of the three modules assigned to the null state. The
i
th cell line will be classified as belonging to the j
th class, if pij.0.5.
It is possible that all pij are less than 0.5; in such a case, the
differentiation status will be classified as unknown.
Identification of differential regions
ANOVA analysis (F-test) was used to detect differential regions
(bin/gene), where the histone modification patterns change
significantly in accordance to the differentiation status. The null
hypothesis was there were no systematic differences across
different cell-lineage groups. This test was conducted via the
multtest package in R [40]. To correct for the multiple hypothesis
testing bias, we calculated the FDR values by using 100,000
random permutations [41]. A cutoff value of FDR=0.05 was used
to select differential regions.
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Figure S1 Determining number of chromatin states by
using the gap statistic. The expected and observed log (WK)
values are shown in (a) for various levels of K (the number of
clusters), where WK is the pooled within cluster sum of squares
around the cluster means. The number of clusters versus Gap(K),
the difference between the observed and expected values (mean
value for 1000 random bootstrap permutations), is shown in (b).
According to these results, three is the optional number of clusters
for our data.
(EPS)
Figure S2 Proportion of bivalent genes in different
chromatin states identified by HMM. Red – active state;
yellow – null state; blue – nonactive state.
(EPS)
Figure S3 Overall distribution of the differential bins
identified by the ANOVA analysis. (a) A Venn diagram
showing the overlap among different histone modifications. (b)
Enrichment of various functional elements in the differential bins,
where the enrichment scores were computed by ratio between the
frequency of differential bins falling into one functional element
category and that expected by chance.
(EPS)
Figure S4 Overall distribution of the differential genes
identified by applying the ANOVA analysis to gene-level
scores. (a) A Venn diagram showing the overlap among different
histone modifications. (b–e) Heatmap of gene-level scores for the
100 most differential genes: (b) H3K4me3. (c) H3K9ac. (d)
H3K27me3. (e) H3K36me3. The cell line information is shown at
both sides of the heatmap and color-coded by the differentiation
status (black – pluripotent (P) cells; red – multipotent (M); green –
unipotent/differentiated (U/D)).
(EPS)
Figure S5 Functional analysis of ‘‘hotspot’’ genes.
‘‘Hotspot’’ genes were identified by applying ANOVA analysis
to the chromatin states inferred by the hidden Markov model.
These genes were further divided into three categories based on
their corresponding state in the ES cells: red – active; yellow – null;
blue – nonactive.
(EPS)
Table S1 Description of the cell lines used in this study.
Code used for cell-type group: P – pluripotent cell; M –
multipotent cell; U/D – unipotent/differentiated cell; C – cancer
cell.
(XLSX)
Table S2 Mean (standard deviation) gene-level histone
modification scores associated with each chromatin
state identified by the hidden Markov model. The active
state is associated with active marks, the non-active state is
associated with the repressive mark H3K27me3, and the null state
is not associated with any mark examined here.
(XLSX)
Table S3 Cell-type specific chromatin states inferred by
the hidden Markov model. (1 – null; 2 – nonactive; 3 – active).
(XLSX)
Table S4 List of differential bins for each histone
modification mark.
(XLSX)
Table S5 List of differential genes based on gene-level
scores for each histone modification mark.
(XLSX)
Table S6 List of ‘‘hotspot’’ genes whose chromatin
states are significantly associated with differentiation
status.
(XLSX)
Table S7 List of genes whose chromatin states are
significantly different between pluripotent cells and
other normal cell types.
(XLSX)
Table S8 List of genes whose chromatin states are
significantly different between the normal and cancer
cell lines.
(XLSX)
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